Stay updated on HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Sign up to get notified when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.

Latest updates to the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedAdded revision marker v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange Detected- The page’s revision tag updated from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.0%

- Check50 days agoChange DetectedA new revision entry (v3.4.2) was added and the previous revision (v3.4.1) was removed from the page history. This is a minor update to the history display and does not alter the study record data.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.1 was added to the history and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check80 days agoChange DetectedOn 2026-01-12, a new revision (v3.3.4) adds the Study Status and Contacts/Locations sections to the record and supersedes v3.3.3.SummaryDifference0.3%

- Check101 days agoChange DetectedA new revision label (v3.3.3) was added and the HHS Vulnerability Disclosure link along with the v3.3.2 revision note were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HELIOS-B: Vutrisiran in TTR Amyloidosis Cardiomyopathy Clinical Trial page.